Document is current

Article History

Received: 18 November 2025

Accepted: 12 February 2026

First Online: 5 March 2026

Change Date: 18 March 2026

Change Type: Update

Change Details: The original online version of this article was revised due to incorrect family name of "Sabine Collaud Basset". Now, the family name of the author has been corrected from "Basset" to "Collaud Basset" .

Declarations

:

: Kulawan Rojananuangnit, Thanapong Somkijrungroj, Teeravee Hongyok, Duangdao Thatsnasong, and Noppakhun Panyayingyong are investigators in the VISCAT study and received financial support from TRB Chemedica (Thailand) Ltd. for their efforts. Teeravee Hongyok reports a relationship with TRB Chemedica (Thailand) Ltd. that includes honoraria fees, funding/hospitality to support attendance at conferences and travel reimbursement. Kulawan Rojananuangnit reports additional relationships with TRB, Santen, Bausch & Lomb, AbbVie, Alcon, and Johnson & Johnson, which include honoraria fees and travel reimbursement. Noppakhun Panyayingyong reports a relationship with TRB Chemedica (Thailand) Ltd. that includes honoraria fees. Sabine Collaud Basset is an employee of TRB Chemedica International SA.

: This study was planned and conducted following the Declaration of Helsinki, Good Clinical Practice, and applicable local regulatory requirements. There was no lead ethics committee; each study site obtained approval from their local ethics committee (Ethics Committee on Research Involving Human Subjects Rajavithi Hospital, Mettapracharuk Hospital and Institutional Review Board Faculty of Medicine Chulalongkorn University) for the study-related documents, as required, before their implementation. Participation in this study was entirely voluntary, and all study participants provided written informed consent before any study assessments or procedures were started.